Health Talks — Psychedelics as Therapeutics: Current Science and Clinical Applications

Do psychedelic drugs offer effective treatment options for health care providers and their patients?

Mind-altering drugs like ketamine, psilocybin mushrooms and MDMA, also known as ecstasy or molly, have sparked controversy within health care fields for decades. Today these drugs are widely studied as a possible treatment for health challenges such as addiction, depression and post-traumatic stress disorder. Join us as our health experts explore the evidence-backed science, benefits and risks behind psychedelic usage in clinical care.

ASU’s College of Health Solutions offers its Health Talks speaker series to inspire collaboration and conversation on important topics in health. Each webinar is offered at no charge and approved for one continuing education credit.